Trastuzumab-Modified Gold Nanoparticles Labeled with <sup>211</sup>At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
Highly localized radiotherapy with radionuclides is a commonly used treatment modality for patients with unresectable solid tumors. Herein, we propose a novel α-nanobrachytherapy approach for selective therapy of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. This u...
Main Authors: | Łucja Dziawer, Agnieszka Majkowska-Pilip, Damian Gaweł, Marlena Godlewska, Marek Pruszyński, Jerzy Jastrzębski, Bogdan Wąs, Aleksander Bilewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/9/4/632 |
Similar Items
-
Synthesis, Characterization, and Therapeutic Efficacy of <sup>177</sup>Lu-DMSA@SPIONs in Nanobrachytherapy of Solid Tumors
by: Dragana Stanković, et al.
Published: (2023-07-01) -
Enhancing the Therapeutic Effect of 2-<sup>211</sup>At-astato-α-methyl-L-phenylalanine with Probenecid Loading
by: Hirofumi Hanaoka, et al.
Published: (2021-11-01) -
Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with <sup>211</sup>At Using Implanted Mouse Tumor
by: Yoshiharu Yonekura, et al.
Published: (2022-12-01) -
Comparison of the Therapeutic Effects of [<sup>211</sup>At]NaAt and [<sup>131</sup>I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model
by: Tadashi Watabe, et al.
Published: (2022-08-01) -
Nanoparticles in Targeted Alpha Therapy
by: Agnieszka Majkowska-Pilip, et al.
Published: (2020-07-01)